Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China

Objective: This study was aimed to investigate the cost-effectiveness of all available programmed death 1 (PD-1) inhibitors combined with chemotherapy in the first-line treatment of advanced esophageal squamous-cell carcinoma (ESCC) from the Chinese healthcare system perspective. Methods: A partitio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shixian, Dou, Lei, Li, Shunping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017726/
https://www.ncbi.nlm.nih.gov/pubmed/36937861
http://dx.doi.org/10.3389/fphar.2023.1055727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017726/
https://www.ncbi.nlm.nih.gov/pubmed/36937861
http://dx.doi.org/10.3389/fphar.2023.1055727

Ejemplares similares